Episode: NINDS Director Story Landis: On Retirement, New Research Directions


Neurology Today - Neurology Today Podcast Logo
Subscribe
NINDS Director Story Landis: On Retirement, New Research Directions
Story Landis, PhD, director of the National Institute of Neurological Disorders and Stroke for more than a decade, has announced that she will retire this fall. In this podcast, Dr. Landis speaks with Neurology Today about her groundbreaking work with the NINDS, her decision to retire, and where she believes research in neurology is heading next. For more information, see the associated article in the September 4 issue of Neurology Today.

Neurology Today - Neurology Today Podcast
Users who viewed this episode also viewed...

Neurology Today - Neurology Today Podcast > Dr. Reisa A. Sperling: The Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease Trial

What could the findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease trial (A4) — a new secondary prevention trial in older people with amyloid accumulation at high risk for Alzheimer’s disease dementia — mean for Alzheimer’s disease? Earlier detection and possibly earlier intervention, according to the lead author of the A4 trial...

Neurology Today - Neurology Today Podcast > Lasker Awardees Richard H. Scheller, PhD, and Thomas C. Südhof, MD: Discovering the Molecular Underpinnings of Neurotransmission

In September, Richard H. Scheller, PhD, and Thomas C. Südhof, MD, were awarded with the 2013 Lasker Award for Basic Medical Research for their independent efforts to unravel the molecular events that underlie the regulation of the release of neurotransmitters at the synapse. In a podcast interview with Neurology Today, they describe their research and what their basic findings could mean for neurological diseases and disorders...

Neurology Today - Neurology Today Podcast > Dr. Vijayshree Yadav Discusses Complementary and Alternative Medicine for MS

Despite the growing number of disease-modifying therapies for multiple sclerosis (MS), a major gap remains when it comes to treatments that are both safe and effective in the long term. So it is no surprise that many MS patients turn to complementary and alternative medicine (CAM) to try to reduce the disease burden...
Comments (0)

Login or Sign up to leave a comment.

Log in
Sign up

Be the first to comment.